Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 18Prostatic Neoplasms 16Colorectal Neoplasms 14Neoplasms 12Hematopoietic and Lymphatic System Neoplasm 12Lung Neoplasms 9Hematologic Neoplasms 8Ovarian Neoplasms 5Multiple Myeloma 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Malignant Solid Neoplasm 4Lymphoma 4Urinary Bladder Neoplasms 3Hematopoietic and Lymphoid System Neoplasm 3Advanced Malignant Solid Neoplasm 3Triple Negative Breast Neoplasms 2Thyroid Cancer, Papillary 2Pancreatic Neoplasms 2Oropharyngeal Neoplasms 2Obesity-Related Malignant Neoplasm 2Mouth Neoplasms 2Motor Activity 2Melanoma 2Malignant Female Reproductive System Neoplasm 2Leukemia, Myeloid, Acute 2Leukemia 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2Head and Neck Neoplasms 2Genetic Predisposition to Disease 2

Interventions

Specimen Handling 1Psilocybin 1Interviews as Topic 1Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Depressive Disorder × Interviews as Topic × 1 year × Clear all
NCT07216404 2026-05-14

Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting
10 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Depressive Disorder

Data powered by HemOnc (CC BY 4.0) Colophon âš¡